ALLMedicine™ Hepatitis Center
Research & Reviews 37,550 results
https://www.mdedge.com/fedprac/article/254637/hepatocellular-carcinoma/psychosocial-barriers-and-their-impact
Parul D. Agarwal, MD, Beth A. Haftoglou, RN et. al.
May 16th, 2022 - Hepatocellular carcinoma (HCC) remains a major global health problem and is the third leading cause of cancer-related mortality worldwide. 1 Management of HCC is complex; as it largely occurs in the background of chronic liver disease, its manageme.
https://doi.org/10.1111/apt.16969
Alimentary Pharmacology & Therapeutics; Rattan P, Shah VH
May 15th, 2022 - Alcohol-associated hepatitis is an acute manifestation of alcohol-associated liver disease (ALD) and is associated with 30%-40% mortality at 28 days. Abstinence and corticosteroids are the mainstays of treatment, but the latter only improves short...
https://doi.org/10.1111/jvh.13699
Journal of Viral Hepatitis; Xu Y, Qi W et. al.
May 15th, 2022 - The study aimed to investigate the role of AR/CCRK signaling pathway in chronic hepatitis B virus (HBV) infection and gender differences, and the contribution of AR regulatory factor STAT3 in it. AR, CCRK, and phosphorylated STAT3 expressions in l...
https://doi.org/10.1002/hep.32572
Hepatology (Baltimore, Md.); Efe C, Kulkarni AV et. al.
May 15th, 2022 - A few case reports of autoimmune hepatitis like liver injury have been reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. We evaluated clinical features, treatment response and outcomes of liver injury followi...
https://doi.org/10.1186/s12879-022-07444-w 10.1099/jgv.0.001415 10.1159/000360947 10.1016/j.jhep.2017.07.011 10.1046/j.1365-2893.1999.00174.x 10.1101/cshperspect.a021436 10.1111/j.1365-2893.2005.00692.x 10.3851/IMP1454 10.1053/j.gastro.2006.01.035 10.1111/liv.13018 10.1086/598955 10.1002/hep.29574 10.1016/j.jhep.2020.04.008 10.1016/j.jhep.2016.02.013 10.1016/j.jhep.2019.12.028 10.1093/infdis/174.5.920 10.1007/3-540-29802-9_9 10.1016/j.jhep.2021.03.025 10.1002/jmv.21294 10.1099/vir.0.83660-0 10.1111/jvh.13086 10.1371/journal.pone.0157161 10.1099/0022-1317-82-11-2709 10.26442/00403660.2020.01.000505 10.1007/s00705-011-1120-y 10.1128/JCM.01154-10 10.1099/jgv.0.001150 10.1093/molbev/msw054 10.1385/1-59259-669-X:115 10.1038/s41586-018-0097-z 10.1002/hep.25852 10.1371/journal.ppat.1006750 10.1099/jgv.0.000878 10.3390/vaccines9020082 10.3390/v11110995 10.1128/JCM.38.9.3311-3316.2000
BMC Infectious Diseases; Karlsen AA, Kyuregyan KK et. al.
May 14th, 2022 - The geographic distribution of the hepatitis B virus (HBV) and the hepatitis D virus (HDV) genotypes is uneven. We reconstructed the temporal evolution of HBV and HDV in Yakutia, one of the regions of Russia most affected by HBV and HDV, in an att...
Guidelines 105 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013624
Clinical and Molecular Hepatology;
Apr 18th, 2022 - KASL clinical practice guidelines for management of chronic hepatitis B.|2022| ,|therapeutic use,genetics,drug therapy,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979596
MMWR. Morbidity and Mortality Weekly Report; Weng MK, Doshani M et. al.
Apr 1st, 2022 - Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). However, vaccination coverage among adults has been suboptimal, limiting further reduction in hepatitis B virus (HBV) infections in...
https://doi.org/10.1016/j.clinre.2022.101871
Clinics and Research in Hepatology and Gastroenterology; Duclos-Vallée JC, Debray D et. al.
Feb 3rd, 2022 - Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis.|2022|Duclos-Vallée JC,Debray D,De Martin E,Beux EL,Louvet A,|
https://doi.org/10.1016/j.clinre.2021.101773
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.
Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...
https://doi.org/10.1016/j.clinre.2021.101772
Clinics and Research in Hepatology and Gastroenterology; Lemoinne S, Heurgue A et. al.
Aug 1st, 2021 - Autoimmune hepatitis (AIH) is a liver disease characterised by necrotico-inflammatory lesions of hepatocytes, the presence of specific autoantibodies and response to corticosteroid treatment. AIH must be considered in any patient with acute or chr...
Drugs 427 results see all →
Clinicaltrials.gov 1,541 results
https://clinicaltrials.gov/ct2/show/NCT04926285
May 13th, 2022 - This is a Phase Ib study of VEN and OM, the investigator will conduct a Bayesian Optimal Interval-designed trial following the approach of Yuan et al 40 to find the MTD with a target DLT rate of 2%, 4 pre-specified doses, and between 24 and up to ...
https://clinicaltrials.gov/ct2/show/NCT00001971
May 13th, 2022 - This is a general clinical research protocol to allow for evaluation, investigation and long-term follow up of patients who have an acute or chronic liver disease. The protocol is designed to study the natural history and pathogenesis of various l...
https://clinicaltrials.gov/ct2/show/NCT03520660
May 13th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...
https://clinicaltrials.gov/ct2/show/NCT05372874
May 13th, 2022 - Patients with hepatitis c showed increased level of oxidative stress. Increased level of serum lipid peroxidation leads to the production of toxic mediators as malondialdehyde (MDA) which lead to disease progression. Chronic stress shunt tryptopha...
https://clinicaltrials.gov/ct2/show/NCT05357183
May 12th, 2022 - Chronic hepatitis B seriously endangers the health of our people, especially the occurrence of liver cancer, which brings huge economic burden and life threat to our people. 84% - 92% of hepatocellular carcinoma (HCC) in China is related to chroni...
News 4,019 results
https://www.mdedge.com/fedprac/article/254637/hepatocellular-carcinoma/psychosocial-barriers-and-their-impact
Parul D. Agarwal, MD, Beth A. Haftoglou, RN et. al.
May 16th, 2022 - Hepatocellular carcinoma (HCC) remains a major global health problem and is the third leading cause of cancer-related mortality worldwide. 1 Management of HCC is complex; as it largely occurs in the background of chronic liver disease, its manageme.
https://www.mdedge.com/familymedicine/article/254556/dermatology/smooth-plaque-ankle
MDedge Family Medicine;
May 12th, 2022 - A 4-mm punch biopsy of the annular border confirmed a diagnosis of localized granuloma annulare (GA). There is a long list of differential diagnoses for annular patches and plaques; it includes tinea corporis and important systemic diseases such a.
https://www.medscape.com/viewarticle/973893
May 12th, 2022 - The CDC updated its recommendations for doctors and public health officials regarding the unusual outbreak of acute hepatitis among children. As of May 5, the CDC and state health departments are investigating 109 children with hepatitis of unknow...
https://www.medscape.com/viewarticle/973791
May 11th, 2022 - A complaint filed with the US Department of Justice (DOJ) alleges that Alabama's Medicaid program is illegally denying curative drug treatment for hepatitis C virus (HCV) infection to people with substance use disorder. The complaint was filed May...
https://www.onclive.com/view/fda-lifts-partial-clinical-hold-placed-on-studies-evaluating-magrolimab-in-mds-and-aml
May 7th, 2022 - The FDA has lifted a partial clinical hold that had been placed on studies examining magrolimab in combination with azacitidine following a review of comprehensive safety data collected from each trial, according to an announcement from Gilead Sci...